BioNTech-Health Economics and Outcomes Research; HEOR Postdoctoral Research Fellow

About the Opportunity

Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.

D. graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, BioNTech is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Berkeley Heights, NJ.

BioNTech is a Germany-based biotechnology company with U.S. offices in Cambridge, MA, Berkeley Heights, NJ and Gaithersburg, MD, that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Bristol Myers Squibb, Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, Medi Link, OncoC4, Pfizer and Regeneron.

At BioNTech, we are more than just a biotechnology company – we are a community of innovators, scientists, and leaders dedicated to revolutionizing medicine by translating cutting-edge science into survival. Your contributions here have the potential to improve the health of people worldwide, especially by addressing diseases with high medical needs like cancer and various infectious diseases. Experience a dynamic workplace that embraces diversity in all its forms.

We foster innovation, encourage creativity, and develop business strategies driven by our shared passion for advancing medicine. Working at BioNTech means striving to achieve medical breakthroughs while growing your career in a meaningful way. Become part of a mission that has the potential to change lives around the world. BioNTech does not tolerate discrimination, favoritism or harassment based on gender, political views, religion or belief, nationality, ethnic or social origin, age, sexual orientation, marital status, disability, physical appearance, health status or any other physical or personal characteristics.

BioNTech is committed to creating a diverse and inclusive work environment. We are proud to be an equal opportunity employer. The main thing is that you suit us, and we suit you!

As healthcare faces significant financial challenges globally, pharmaceutical/biotechnology companies are working to holistically assess and communicate the value of their products to patients, physicians and payers. The two-year Health Economic & Outcomes Research (HEOR) Fellowship is designed to develop Pharm

D graduates with the goal of understanding the dynamic healthcare ecosystem through hands on experience. Throughout the two-year program, the fellows will learn to identify the clinical, economic, and humanistic value drivers of BioNTech products. They will learn advanced techniques to quantify the value, communicate the findings in scientific congresses & peer reviewed publications, and compliantly engage stakeholders (US population health decision makers and/or HTA bodies) on the value of BioNTech’s innovative products.

• Work on products across the Oncology and Infectious disease therapeutic areas at BioNTech
• Learn through hands‑on experience and understand how global HEOR provides strategic inputs to address the specific value challenges for each individual therapy
• Be fully integrated with the cross‑functional environment (Medical Affairs, Market Access, Commercial, Biostatistics, Regulatory, Safety, Clinical Development and Clinical Operations) and work collaboratively to assess the value of the asset…